BioSpace News Archive

BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2022

Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, announced today that the Company will host a hybrid Investor Day on Friday, October 29, 2021.

COVID-19 vaccine recipients had lower non-COVID-19 death rates than people who weren’t vaccinated, according to Kaiser Permanente research published October 22, 2021 in the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report.

NeoCura Bio-Medical Technology Co., Ltd, a leading AI-enabled RNA precision medicine company based on research, development and MDimune Inc., a leading extracellular vesicle (EV)-based drug delivery platform company, has announced the signing of collaboration focused on mRNA delivery for oncological therapeutics.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Susvimo™ (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant for the treatment of people with wet, or neovascular, age-related macular degeneration (AMD) who have previously responded to at least two anti-vascular endothelial growth factor (VEGF) injections

Kala Pharmaceuticals, Inc., announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635.

Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that study investigators of the Multi-Center ESG Randomized Interventional Trial (MERIT) presented positive outcomes.

BioCareSD, a specialty distributor of life-saving therapies, today announced the addition of UPLIZNA® to its specialty therapeutics portfolio to service a wider patient population and broaden the company’s diverse product offering.

Advanced Radiation Therapy, LLC (ART) and Apollo Healthcare have today announced a strategic partnership aimed at easing the challenge radiation oncology clinics have in pre-authorizing patients for insurance coverage for innovative radiation cancer therapies.

Niemann-Pick disease is a rare advanced genetic cholesterol storage disorder. It is characterized by the body’s inability to transport cholesterol and other fatty substances into the cells.